This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Laboratoire Francais Du Fractionnement Et Des. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Serge Martel
Introduction
Serge Martel is a notable inventor based in La Madeleine, France. He has made significant contributions to the field of biotechnology, particularly in the preparation of von Willebrand factor concentrates. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Martel holds a patent for a process titled "Process for the preparation of a von Willebrand (FvW) factor concentrate by chromatography." This invention focuses on a method to achieve a very high purity von Willebrand factor concentrate from a biological fraction. The process involves anion exchange chromatography using a vinyl polymer support of weak base type. Key steps include loading the chromatographic support with the fraction, washing it with an acidic buffer, and eluting the von Willebrand factor by increasing the ionic strength. This innovative approach is crucial for producing a von Willebrand factor concentrate for therapeutic use, with a specific rate of Factor VIII:C/FvW:RCo being less than 0.06%.
Career Highlights
Throughout his career, Serge Martel has worked with prominent organizations such as Laboratoire Français Du Fractionnement Et Des Biotechnologies. His experience in these institutions has allowed him to refine his expertise in biotechnology and contribute to significant advancements in the field.
Collaborations
Martel has collaborated with notable colleagues, including Sami Chtourou and Michel Poulle. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Serge Martel's contributions to the field of biotechnology, particularly through his patented process for von Willebrand factor concentrate, highlight the importance of innovation in healthcare. His work exemplifies how dedicated inventors can drive advancements that have a meaningful impact on therapeutic practices.